Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)-Reference-Cited by-同舟云学术

Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)

Published:2016-08-16 Issue:51 Volume:7 Page:85584-85591
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Yoon Dok Hyun¹,Kim Seok Jin²,Jeong Seong Hyun³,Shin Dong-Yeop⁴,Bae Sung Hwa⁵,Hong Junshik⁶,Park Seong Kyu⁷,Yhim Ho-Young⁸,Yang Deok-Hwan⁹,Lee Hyewon¹⁰,Kang Hye Jin¹¹,Lee Mark Hong¹²,Eom Hyeon-Seok¹⁰,Kwak Jae-Yong⁸,Lee Jae Hoon⁶,Suh Cheolwon¹,Kim Won Seog²

Affiliation:

1. Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

2. Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

3. Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea

4. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea

5. Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea

6. Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea

7. Department of Hematology/Oncology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea

8. Department of Internal Medicine, Chonbuk National University School of Medicine, Jeonju, Korea

9. Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea

10. Center for Hematologic Malignancies, National Cancer Center, Goyang, Korea

11. Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea

12. Department of Hematology-Oncology, Konkuk University Medical Center, Seoul, Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type;Cancer Biomarkers;2023-11-18

2. Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL);Leukemia & Lymphoma;2023-08-21

3. Phase II Study of Peg-Asparaginase, Etoposide, Gemcitabine (PEG) Followed by Involved- Field Radiation Therapy in Early-Stage Extranodal Natural Killer/T-Cell Lymphoma;2023-06-26

4. Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L‐asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T‐cell lymphoma: A French retrospective study;British Journal of Haematology;2023-02-17

5. Treatment of extranodal NK/T-cell lymphoma: From past to future;Frontiers in Immunology;2023-02-07